News

News

Bonn Call for Action, FDA, radiation exposure, medical imaging, update

The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action, an international list of priorities for radiation protection in medicine for the...

Impella, FDA, high risk PCI, abiomed

The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary...

TOTAL trial, thrombectomy, STEMI

Clearing blood clots (thrombectomy) from coronary arteries in about 20 percent of patients undergoing angioplasty...

JAMA, intracranial arterial stenosis, balloon expandable stents, medication

A study in the March 24/31 issue of JAMA found that using balloon-expandable stents to treat symptomatic intracranial arterial stenosis resulted in an increased risk of stroke or...

atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to...

radiation, risk, cancer patients, information, Memorial Sloan Kettering, MSKCC

A new study published online in the journal Radiology found a substantial gap between patient expectations and current practices for providing information about medical imaging tests that...

Patients over age 80 with acute coronary syndromes would likely benefit from more invasive tests and therapies that may otherwise be denied them due to their age, according to research presented...

atients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two coprimary endpoints — a composite...

low-dose radiation, cancer risk, mice, Berkeley National Laboratory, therapy, CT

Scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory  have uncovered new clues about the risk of cancer from low-dose radiation. In this research, low-dose is...

TomTec Imaging Systems GmbH announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest version of its TomTec-Arena software solution.

Biotronik, Eluna, ProMRI, FDA

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its ProMRI Eluna pacemaker system. Biotronik ProMRI technology allows patients to undergo full-body magnetic...

cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy

AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (CRYO2) to provide cryoanalgesia for temporary pain management. AtriCure’s cryoICE is the...

heart failure, BAT, baroreflex activation therapy, William Abraham, CVRx

Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart...

Mitralign, transcatheter triscupid repair, TTVR, TR, first in human

A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for severe TR has been reported by Prof. J. Schofer, M.D., of the Medicare Center and Department...

Mitraclip, abbott, mitral valve repair, ACC, transcatheter mitral valve repair

The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S....

The sixth Image Wisely Radiation Safety Case —Optimizing Radiation Use During a Difficult IVC Filter Retrieval — is now available to help radiologists, imaging technologists and medical...

dual antiplatelet therapy, DAPT, mortality, DES implantation, CRF, length

Data from a meta-analysis published recently in The Lancet found that extended-duration dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation was associated with...

ST2, cardiac biomarker, Critical Diagnostics, heart failure, predict outcomes

According to an abstract presented at the American College of Cardiology (ACC) Scientific Sessions in San Diego, elevated levels of the cardiac biomarker ST2 were associated with an increased risk...

Emblem S-ICD, implantable cardioverter defibrillator, Boston Scientific, FDA, CE

Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) and CE Mark approval of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) system. The Emblem S-ICD system is a...

IntelliSpace Cardiovascular, Philips, CVIS, cardiac PACS

Philips Healthcare launched IntelliSpace Cardiovascular at the American College of Cardiology (ACC) 2015 meeting. The Web-enabled cardiovascular information system (CVIS) offers a single...